|138.80||+0.1300||+0.09%||Vol 1.53M||1Y Perf -33.52%|
|Sep 23rd, 2021 16:00 DELAYED|
|- -||1.07 0.77%|
|Target Price||208.88||Analyst Rating||Moderate Buy 2.10|
|Potential %||50.49||Finscreener Ranking||★★★+ 52.09|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★★ 56.08|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★+ 56.08|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||5.08||Earnings Rating||Strong Sell|
|Market Cap||22.10B||Earnings Date||27th Oct 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||27th Oct 2021|
|Estimated EPS Next Report||-0.70|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||2.78M|
|Avg. Monthly Volume||2.04M|
|Avg. Quarterly Volume||2.27M|
Teladoc Health Inc. (NYSE: TDOC) stock closed at 138.8 per share at the end of the most recent trading day (a 0.09% change compared to the prior day closing price) with a volume of 1.56M shares and market capitalization of 22.10B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 3276 people. Teladoc Health Inc. CEO is Jason N. Gorevic.
The one-year performance of Teladoc Health Inc. stock is -33.52%, while year-to-date (YTD) performance is -30.59%. TDOC stock has a five-year performance of 644.64%. Its 52-week range is between 129.74 and 308, which gives TDOC stock a 52-week price range ratio of 5.08%
Teladoc Health Inc. currently has a PE ratio of -21.10, a price-to-book (PB) ratio of 1.42, a price-to-sale (PS) ratio of 13.25, a price to cashflow ratio of 211.20, a PEG ratio of 2.32, a ROA of -7.57%, a ROC of -7.32% and a ROE of -8.79%. The company’s profit margin is -47.00%, its EBITDA margin is -31.70%, and its revenue ttm is $1.63 Billion , which makes it $10.23 revenue per share.
Of the last four earnings reports from Teladoc Health Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.70 for the next earnings report. Teladoc Health Inc.’s next earnings report date is 27th Oct 2021.
The consensus rating of Wall Street analysts for Teladoc Health Inc. is Moderate Buy (2.1), with a target price of $208.88, which is +50.49% compared to the current price. The earnings rating for Teladoc Health Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Teladoc Health Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Teladoc Health Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 25.90, ATR14 : 4.90, CCI20 : -36.68, Chaikin Money Flow : -0.03, MACD : -2.07, Money Flow Index : 51.49, ROC : -2.92, RSI : 46.05, STOCH (14,3) : 48.73, STOCH RSI : 0.72, UO : 53.02, Williams %R : -51.27), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Teladoc Health Inc. in the last 12-months were: Adam C. Vandervoort (Option Excercise at a value of $459 655), Adam C. Vandervoort (Sold 29 245 shares of value $5 831 181 ), Andrew Turitz (Option Excercise at a value of $120 564), Andrew Turitz (Sold 13 298 shares of value $2 694 002 ), Arnnon Geshuri (Option Excercise at a value of $10 511), Arnnon Geshuri (Sold 19 685 shares of value $3 782 305 ), Catherine Jacobson (Option Excercise at a value of $0), Christopher Bischoff (Option Excercise at a value of $0), Daniel Trencher (Option Excercise at a value of $740 376), Daniel Trencher (Sold 32 580 shares of value $6 243 027 ), David B. Snow (Option Excercise at a value of $0), David L. Shedlarz (Option Excercise at a value of $0), David William Sides (Option Excercise at a value of $0), David William Sides (Sold 6 286 shares of value $1 121 199 ), Glen E. Tullman (Option Excercise at a value of $4 337 690), Glen E. Tullman (Sold 824 656 shares of value $178 984 046 ), Hemant Taneja (Sold 102 449 shares of value $19 989 554 ), Jason N. Gorevic (Option Excercise at a value of $382 156), Jason N. Gorevic (Sold 296 785 shares of value $60 414 383 ), Karen L. Daniel (Option Excercise at a value of $0), Lewis Levy (Option Excercise at a value of $98 604), Lewis Levy (Sold 2 670 shares of value $595 036 ), Mala Murthy (Option Excercise at a value of $0), Mala Murthy (Sold 6 925 shares of value $1 273 555 ), Mark Douglas Smith (Option Excercise at a value of $0), Sandra L. Fenwick (Option Excercise at a value of $0), Sandra L. Fenwick (Sold 7 173 shares of value $1 180 891 ), Stephany Verstraete (Option Excercise at a value of $885 446), Stephany Verstraete (Sold 48 483 shares of value $10 456 302 ), Thomas G. McKinley (Option Excercise at a value of $0), William H. Frist (Option Excercise at a value of $49 522), William H. Frist (Sold 740 shares of value $154 290 ), Yulun Wang (Option Excercise at a value of $221 127), Yulun Wang (Sold 40 830 shares of value $9 846 122 )
Fri, 10 Sep 2021 15:21 GMT Teladoc Stock: Could Cathie Wood Be Wrong- TipRanks. All rights reserved.
Thu, 09 Sep 2021 19:18 GMT Teladoc Health: Can Amazon, Walmart, Be Fought off- TipRanks. All rights reserved.
Wed, 01 Sep 2021 16:00 GMT TDOC Stock Is an Irresistible Stay-at-Home Trade- TipRanks. All rights reserved.
Wed, 04 Aug 2021 12:34 GMT Can Delta Variant Fuel Teladoc Stock Comeback- TipRanks. All rights reserved.
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
This could take some time, please wait.